PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

Overview of attention for article published in Journal of Translational Medicine, October 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 29 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 78 followers.

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive… http://t.co/vsKH14MIcd #JTransMed

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.